ChemDiv

ChemDiv is a long-established, global CRO that leverages a massive chemical library and integrated AI/ML to accelerate drug discovery for pharmaceutical and biotech partners. The company provides end-to-end services, including medicinal chemistry, biology, DMPK, and toxicology, alongside a catalog of over 1.6 million stock compounds and access to a virtual chemical space of trillions of structures. With over 30 years of experience, it claims contributions to 47 approved drugs and serves a broad client base from its five worldwide R&D hubs.

Hybrid Artificial Intelligence (AI)/Machine Learning (ML) platform integrated with a vast chemical library (1.6M stock compounds, 2T virtual space), medicinal chemistry, and discovery biology for accelerated small molecule drug discovery.

ChemDiv competes with large, full-service CROs (e.g., Charles River, Evotec) and chemistry-focused service providers, as well as a growing number of AI-driven drug discovery companies (e.g., Exscientia, Recursion). Its differentiation lies in its long history, integrated AI/ML/human expertise, and ownership of one of the world's largest commercial compound collections.